What is the official website of Stelis Biopharma ?

The official website of Stelis Biopharma is https://www.stelis.com/.

What is Stelis Biopharma's cybersecurity risk score?

Stelis Biopharma has an AI-generated cybersecurity risk score of 757 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Stelis Biopharma experienced?

According to Rankiteo, Stelis Biopharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Stelis Biopharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Stelis Biopharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Stelis Biopharma have SOC 2 Type 1 certification ?

According to Rankiteo, Stelis Biopharma is not certified under SOC 2 Type 1.

Does Stelis Biopharma have SOC 2 Type 2 certification ?

According to Rankiteo, Stelis Biopharma does not hold a SOC 2 Type 2 certification.

Does Stelis Biopharma comply with GDPR ?

According to Rankiteo, Stelis Biopharma is not listed as GDPR compliant.

Does Stelis Biopharma have PCI DSS certification ?

According to Rankiteo, Stelis Biopharma does not currently maintain PCI DSS compliance.

Does Stelis Biopharma comply with HIPAA ?

According to Rankiteo, Stelis Biopharma is not compliant with HIPAA regulations.

Does Stelis Biopharma have ISO 27001 certification ?

According to Rankiteo,Stelis Biopharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Stelis Biopharma operate in ?

Stelis Biopharma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Stelis Biopharma have ?

Stelis Biopharma employs approximately 448 people worldwide.

Does Stelis Biopharma own any subsidiaries ?

Stelis Biopharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Stelis Biopharma have ?

Stelis Biopharma's official LinkedIn profile has approximately 84,382 followers.

What is the NAICS classification code for Stelis Biopharma ?

Stelis Biopharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Stelis Biopharma have a Crunchbase profile ?

No, Stelis Biopharma does not have a profile on Crunchbase.

Does Stelis Biopharma have a LinkedIn profile ?

Yes, Stelis Biopharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/stelisbiosource.

How many cybersecurity incidents has Stelis Biopharma experienced ?

As of September 16, 2026, Rankiteo reports that Stelis Biopharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Stelis Biopharma have ?

Stelis Biopharma has an estimated 5,763 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Stelis Biopharma

Boost Score +25 with badge (5 left)

757

/1000

Fair

782

/1000

Fair

Stelis Biopharma Vendor Cyber Rating & Cyber Score

stelis.com

Add Your Compliance Badge

Stelis Biopharma is a leading, fully integrated biopharmaceutical contract development and manufacturing organization. The powerhouse to progress your biologic products to market as efficiently as possible, we can cater for the entire product lifecycle for our customers for both drug substances and drug products. Our team has deep expertise in product development and manufacturing with comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing and fill/finish of proteins and peptides. From our strategic location in Bangalore, India, we leverage the advantages of an emerging technological hub for R&D and next generation manufacturing. Delivering solutions for your most complex biologic

Stelis Biopharma

Stelis Biopharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Stelis Biopharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Stelis Biopharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Stelis Biopharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Stelis Biopharma in 2026.

Incident Types Stelis Biopharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Stelis Biopharma in 2026.

Incident History - Stelis Biopharma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Stelis Biopharma Subsidiaries

Stelis Biopharma

Pharmaceutical Manufacturing

Website: https://www.stelis.com/

Company Size: 448

StridesPharmaceutical Manufacturing

ArcolabBusiness Consulting and Services

Naari Pharma Pvt Ltd.Pharmaceutical Manufacturing

Solara Active Pharma SciencesPharmaceutical Manufacturing

Strides Pharma CanadaPharmaceutical Manufacturing

InstaPillPharmaceutical Manufacturing

Loading…

Stelis Biopharma Similar Companies

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Loading…

NEWS

Stelis Biopharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 20, 2025 08:00 AM

DMD, DSK advise on USD97m HBM Healthcare pre-IPO round

DMD Advocates represented HBM Healthcare Investments and other investors in leading an INR8.5 billion (USD97.7 million) pre-listing funding.

Read Article

January 08, 2021 08:00 AM

DGFT issues trade advisory for Indian exporters to prevent cyber attacks, fraud activities

To protect Indian exporters from the cyber-attacks and fraud activities, the Directorate General of Foreign Trade (DGFT) has issued a trade...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-85893

SUMMARY

Use after free in Microsoft Edge (Chromium-based) allows an unauthorized attacker to elevate privileges over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-85893

CVE-2026-69486

SUMMARY

Heap-based buffer overflow in Microsoft Edge (Chromium-based) allows an unauthorized attacker to execute code over a network.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-69486

CVE-2025-11395

SUMMARY

A flaw was found in Podman. If an attacker can pass a crafted tar archive to the `podman load` command, they can create files on the host machine with the privileges of the user running Podman.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

Impact Score

3.4

Exploitability

2.1

REFERENCES

CVE-2026-92259

SUMMARY

Integer overflow or wraparound vulnerability in Samsung Opensource Escargot allows attackers with write access to the bytecode-cache directory to cause a heap-based buffer overflow and denial of service via a crafted cache file. This issue affects Escargot: ac94df78493ee6fede286620d94f724e46b4d238.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

1.8

REFERENCES

https://github.com/Samsung/escargot/pull/1650

CVE-2026-92257

SUMMARY

Netcore NR255-V version 1.5.130703 contains a stored cross-site scripting vulnerability in L7 content management pages that use eval() sinks, affecting the call board text and policy group handling components. Attackers can inject persistent script payloads through these pages to have malicious code executed in the context of other users viewing the affected content.

Published

Date2026-09-15

Updated

Date2026-09-15

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.7

Exploitability

2.3

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Stelis Biopharma Vendor Cyber Rating & Cyber Score

Stelis Biopharma A.I CyberSecurity Scoring

Stelis Biopharma CyberSecurity News & History

Stelis Biopharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Stelis Biopharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Stelis Biopharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Stelis Biopharma (X = Date, Y = Severity)

Stelis Biopharma Subsidiaries

Stelis Biopharma

Stelis Biopharma Similar Companies

Sandoz

Servier

AUROBINDO PHARMA LTD

Alembic Pharmaceuticals Limited

Teva Pharmaceuticals

Sanofi

Cipla

MANKIND PHARMA LTD

Novartis

Stelis Biopharma CyberSecurity News

DMD, DSK advise on USD97m HBM Healthcare pre-IPO round

DGFT issues trade advisory for Indian exporters to prevent cyber attacks, fraud activities

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Stelis Biopharma CyberSecurity News & History

Stelis Biopharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Stelis Biopharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Stelis Biopharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Stelis Biopharma (X = Date, Y = Severity)

Stelis Biopharma Subsidiaries

Stelis Biopharma

Stelis Biopharma Similar Companies

Sandoz

Servier

AUROBINDO PHARMA LTD

Alembic Pharmaceuticals Limited

Teva Pharmaceuticals

Sanofi

Cipla

MANKIND PHARMA LTD

Novartis

Stelis Biopharma CyberSecurity News

DMD, DSK advise on USD97m HBM Healthcare pre-IPO round

DGFT issues trade advisory for Indian exporters to prevent cyber attacks, fraud activities

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo